Literature DB >> 29437116

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Laxmi S Mehta, Karol E Watson, Ana Barac, Theresa M Beckie, Vera Bittner, Salvador Cruz-Flores, Susan Dent, Lavanya Kondapalli, Bonnie Ky, Tochukwu Okwuosa, Ileana L Piña, Annabelle Santos Volgman.   

Abstract

Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statement; breast cancer; cardiotoxicity; cardiovascular disease; oncology; prevention; risk factors

Mesh:

Year:  2018        PMID: 29437116      PMCID: PMC6722327          DOI: 10.1161/CIR.0000000000000556

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  173 in total

Review 1.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

Review 2.  Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs.

Authors:  Andreas M Beyer; Marcelo G Bonini; Javid Moslehi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-07       Impact factor: 4.733

3.  Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.

Authors:  Jenica N Upshaw; Robin Ruthazer; Kathy D Miller; Susan K Parsons; John K Erban; Anne M O'Neill; Biniyam Demissei; George Sledge; Lynne Wagner; Bonnie Ky; David M Kent
Journal:  Clin Breast Cancer       Date:  2019-05-02       Impact factor: 3.225

4.  Revisiting Hormonal Control of Vascular Injury and Repair.

Authors:  Daniel Pérez-Cremades; Henry S Cheng; Mark W Feinberg
Journal:  Circ Res       Date:  2020-12-03       Impact factor: 17.367

5.  Cancer Survivorship and Subclinical Myocardial Damage.

Authors:  Roberta Florido; Alexandra K Lee; John W McEvoy; Ron C Hoogeveen; Silvia Koton; Mara Z Vitolins; Chetan Shenoy; Stuart D Russell; Roger S Blumenthal; Chiadi E Ndumele; Christie M Ballantyne; Corinne E Joshu; Elizabeth A Platz; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

Review 6.  Specialized Care for Women: the Impact of Women's Heart Centers.

Authors:  Gina P Lundberg; Laxmi S Mehta; Annabelle S Volgman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-08

7.  Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

Authors:  Dylan J Richards; Yang Li; Charles M Kerr; Jenny Yao; Gyda C Beeson; Robert C Coyle; Xun Chen; Jia Jia; Brooke Damon; Robert Wilson; E Starr Hazard; Gary Hardiman; Donald R Menick; Craig C Beeson; Hai Yao; Tong Ye; Ying Mei
Journal:  Nat Biomed Eng       Date:  2020-04-13       Impact factor: 25.671

Review 8.  The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges.

Authors:  Carolyn J Park; Mary E Branch; Sujethra Vasu; Giselle C Meléndez
Journal:  J Cardiovasc Transl Res       Date:  2020-04-04       Impact factor: 4.132

Review 9.  The breast cancer patient in the cardioncology unit.

Authors:  Daniela Cardinale; Vincenzo Caruso; Carlo M Cipolla
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 10.  Modern concepts in cardio-oncology.

Authors:  Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.